Skip to main content
. 2024 Feb 15;11(3):1567–1579. doi: 10.1002/ehf2.14700

Table 3.

Univariate and multivariate regression analysis for HF in all subjects

Univariate Multivariate model 1 Multivariate model 2
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Sex (male) 0.964 (0.561–1.656) 0.893 0.950 (0.490–1.843) 0.879
Age 1.199 (0.762–1.886) 0.433 0.862 (0.487–1.526) 0.611
BMI 0.769 (0.547–1.080) 0.130 0.762 (0.511–1.135) 0.181
Low systolic BP 1.810 (1.128–2.906) 0.014 1.915 (1.128–3.250) 0.016 1.875 (1.076–3.268) 0.027
Heart rate 3.165 (1.558–6.430) 0.001 3.158 (1.440–6.924) 0.004 3.077 (1.351–7.010) 0.007
Smoking 1.033 (0.638–1.671) 0.896 0.883 (0.449–1.736) 0.719
Drinking 1.688 (0.919–3.101) 0.091 2.456 (1.097–5.501) 0.029
Diabetes 1.794 (1.074–2.996) 0.025 1.699 (0.946–3.051) 0.076
Hyperlipidaemia 0.466 (0.218–0.997) 0.049 0.498 (0.207–1.199) 0.120
Stroke 0.792 (0.390–1.608) 0.519 0.808 (0.364–1.796) 0.602
AF 1.055 (0.633–1.758) 0.837 0.740 (0.412–1.330) 0.314
Coronary disease 0.734 (0.461–1.168) 0.191 0.648 (0.364–1.153) 0.140
ALT 1.054 (0.672–1.652) 0.819 1.025 (0.614–1.713) 0.924
Low eGFR 2.239 (1.655–3.029) <0.001 2.469 (1.731–3.522) <0.001 2.520 (1.806–3.517) <0.001
Tyr/Thr tertiles 3.225 (2.307–4.507) <0.001 3.510 (2.445–5.040) <0.001

Model 1, adjusted for conventional HF risk factors; Model 2, adjusted for low systolic BP, heart rate, low eGFR and with the addition of the tertiles of Tyr/Thr.

95% CI, 95% confidence interval; AF, atrial fibrillation; ALT, alanine transaminase; BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; HF, heart failure; OR, odds ratio; Tyr/Thr, tyrosine/threonine.